ABL1 promoter methylation can exist independently of BCR-ABL transcription in chronic myeloid leukemia hematopoietic progenitors

Cancer Research

Volumn 61, Issue 18, 2001, Pages 6931-6937

  Sun, B ^a   Jiang, G ^a   Zaydan, M A A ^a   La Russa, V F ^a   Safah, H ^a   Ehrlich, M ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; BISULFITE; DNA; RNA;

ADULT; AGED; ARTICLE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN TISSUE; MALE; METHYLATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; AGED; BASE SEQUENCE; BONE MARROW CELLS; DNA METHYLATION; FEMALE; GENE EXPRESSION; GENES, ABL; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA, MYELOID, CHRONIC; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC; TUMOR STEM CELLS;

EID: 0035884194     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. The Philadelphia chromosome translocation. A paradigm for understanding leukemia
2. The ABL oncogene in human leukemias
3. Regulated expression of P210 Bcr-Abl during embryonic stem cell differentiation stimulates multipotential progenitor expansion and myeloid cell fate
4. Signaling pathways activated by oncogenic forms of Abl tyrosine kinase
5. BCR-ABL tyrosine kinase activity regulates the expression of multiple genes implicated in the pathogenesis of chronic myeloid leukemia
6. Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene
7. Studies of BCR and ABL gene rearrangements in chronic myelogenous leukemia patients by conventional and pulsed-field gel electrophoresis using gel inserts
8. Molecular follow-up of disease progression and interferon therapy in chronic myelocytic leukemia
9. DNA hypomethylation and cancer
10. Hypermethylator phenotypes in aging and cancer
11. Epigenetics, and loss of gene function in cancer
12. DNA methylation: Past, present and future directions
13. Methylation of the ABL1 promoter in chronic myelogenous leukemia: Lack of prognostic significance
14. Quantitative measure of c-abl and p15 methylation in chronic myelogenous leukemia: Biological implications
15. ABL1 methylation is a distinct molecular event associated with clonal evolution of chronic myeloid leukemia
16. Reverse transcription/polymerase chain reaction (RT/PCR) amplification of very small numbers of transcripts: The risk in misinterpreting negative results
17. A bisulfite method of 5-methylcytosine mapping that minimizes template degradation
18. Bisulfite sequencing in preimplantation embryos: DNA methylation profile of the upstream region of the mouse imprinted H19 gene
19. Detection and measurement of PCR bias in quantitative methylation analysis of bisulphite-treated DNA
20. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
21. Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: Correlations with acute graft-versus-host disease and relapse
22. Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation
23. Comparison of bisulfite modification of 5-methyl-deoxycytidine and deoxycytidine residues
24. High sensitivity mapping of methylated cytosines
25. COBRA: A sensitive and quantitative DNA methylation assay
26. Progressive de novo DNA methylation at the bcr-abl locus in the course of chronic myelogenous leukemia
27. Detection of bcr-abl mRNA in single progenitor colonies from patients with chronic myeloid leukemia by PCR: Comparison with cytogenetics and PCR from uncultured cells
28. BCR-ABL-positive progenitors in chronic myeloid leukaemia patients in complete cytogenetic remission after treatment with interferon-α
29. BCR-ABL, ABL-BCR, and ABL genes are all expressed in individual granulocyte-macrophage colony-forming unit colonies derived from blood of patients with chronic myeloid leukemia
30. Reverse transcription polymerase chain reaction is a reliable assay for detecting leukemic colonies generated by chronic myelogenous leukemia cells
31. Variable transcription of BCR-ABL by Ph+ cells arising from hematopoietic progenitors in chronic myeloid leukemia
32. Distinct patterns of inactivation of p151NK4B and p161NK4A characterize the major types of hematological malignancies
33. Hypermethylation of the DAP-kinase CpG island is a common alteration in B-cell malignancies
34. Acceleration of chronic myeloid leukemia correlates with calcitonin gene hypermethylation
35. Abnormal methylation of the calcitonin gene marks progression of chronic myelogenous leukemia
36. Aberrant methylation of the major breakpoint cluster region in chronic myeloid leukemia